1. Allhoff EP, Proppe KH, Chapman CM, Lin C-W, Prout GR (1983) Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer. J Urol 129:315–318
2. Allhoff EP, Oette K, Franzen W, Engelking R (1986) Importance of a multiple marker system for the diagnosis and monitoring of prostate cancer. In: Greten H, Klapfor R (eds) Clinical relevance of new monoclonal antibodies. Third symposium on tumor markers. Georg Thieme, Stuttgart New York, pp 208–213
3. Baylin SB, Mendelsohn G (1982) Time-dependent changes in human tumors: implications for diagnosis and clinical behaviour. Semin Oncol 9:504–512
4. Emtage LA, Lewis PW, Blackledge GRP (1987) The role of prostate specific antigen in the baseline assessment of patients undergoing hormone therapy for advanced prostate cancer. Br J Urol 60:572–577
5. Hermanek P, Sobin LH (1987) TNM classification of malignant tumors, 4th edn. Springer, Berlin Heidelberg New York London Paris Tolyo, pp 124–129